Compensatory activation of the insulin receptor (IR) and its mitogenic ligand IGF2 is triggered in some Ewing sarcoma cells in response to IGF2BP3 mediated IGF1R loss [318]. The gene discussed is IGF2BP3; the disease is Ewing sarcoma.